Continuous glucose monitoring (CGM) paired with meal logging, labs, and optional dietitian sessions. Three tiers: $15/mo (app only), $41/mo (1 month CGM + 2 lab panels + clinician review), or $167/mo (2 months CGM + comprehensive labs + nutritionist sessions). Best if you want coaching layer alongside the data.
Multiple RCTs and observational studies show that CGM use with behavioral feedback reduces HbA1c (glycated hemoglobin) in people with type 2 diabetes and prediabetes, and improves glucose variability metrics. Real-world data also supports CGM-guided dietary changes in non-diabetic populations for reducing postprandial (after-meal) glucose spikes. The combination of CGM + coaching amplifies adherence and outcomes compared to CGM alone.
A continuous glucose monitor (CGM) is a wearable sensor that measures interstitial glucose levels every 5–15 minutes, providing real-time feedback on how foods, exercise, and stress affect blood sugar. Health coaching uses this data to help users identify patterns, optimize meal timing and composition, and reduce glucose variability—which may lower inflammation, improve energy, and reduce diabetes risk.
EOD publishes opinions and summaries of research about supplements, services, and protocols. It is not medical advice. Consult a qualified healthcare provider before changing your supplement, exercise, sleep, or medication regimen.
Some outbound links on EOD are affiliate links. If you buy through them we may earn a small commission, at no extra cost to you. It never influences what we publish or how it's ranked. Full disclosure.
EOD · 123 Placeholder Street, New York, NY 10001
May be an affiliate link.
Randomized trial
“OBJECTIVE: To compare the 12-month effects of continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) in adults with insulin-treated type 2 diabetes.”
“Conflict of interest statement: Conflict of Interest Disclosures: All authors received grant funding from Dexcom to their institution for the conduct of the submitted study.”
“Objective: Continuous glucose monitoring (CGM) is an effective tool for individuals with type 2 diabetes (T2D) on insulin.”
“It can scarcely be denied that the supreme goal of all theory is to make the irreducible basic elements as simple and as few as possible without having to surrender the adequate representation of a single datum of experience.”
Most RCT evidence focuses on people with existing diabetes or prediabetes; fewer rigorous trials exist in healthy, non-diabetic users seeking optimization. Long-term adherence and cost-effectiveness remain understudied. Some studies show modest HbA1c reductions (0.3–0.5%) in well-controlled type 2 diabetes, raising questions about clinical significance in that subgroup. Coaching quality varies widely and is not standardized across vendors.
0 comments
Join the conversation. Members can comment, verify, and save finds. Free.
Sign in to comment